Impaired hydroxylation of 5-methylcytosine in myeloid cancers with mutant TET2
Myunggon Ko, Yun Huang(La Jolla Institute for Immunology), A. Jankowska(Cleveland Clinic), Utz Johann Pape(Boston Children's Hospital), Mamta Tahiliani(Harvard University), Hozefa S. Bandukwala(Boston Children's Hospital), Jungeun An(La Jolla Institute for Immunology), Edward D. Lamperti(Harvard University), Kian Peng Koh(Harvard University), Rebecca Ganetzky(Cleveland Clinic), X. Shirley Liu(Dana-Farber Cancer Institute), L. Aravind(National Center for Biotechnology Information), Suneet Agarwal(Dana-Farber Cancer Institute), Jaroslaw P. Maciejewski(Cleveland Clinic), Anjana Rao(Harvard University)
Cited by 1,277
Abstract
Related Papers
Mutation in <i>TET2</i> in Myeloid Cancers
François Delhommeau, Sabrina Dupont, Véronique Della Valle et al.|New England Journal of Medicine|2009|1.7k